We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Visualization System Assists Cardiac Ablation

By HospiMedica staff writers
Posted on 09 Oct 2006
A new visualization system enables physicians to perform less-invasive cardiac surgical ablation procedures.

The FlexView system enables physicians to perform minimally invasive thoracoscopic cardiac ablation procedures with a surgical ablation probe in a closed chest environment, with direct visualization of the procedure at all times. More...


The microwave surgical ablation can be performed in combination with valve or coronary artery bypass surgeries or in minimally invasive, stand-alone procedures. The new system is the first system designed specifically for less-invasive, unilateral procedures, and patients who undergo the procedure should recover faster and with less pain than with procedures that require rib spreading. Using specialized routing and retrieval tools, the system may reduce overall procedure time by 30 minutes or more.

"The future of cardiac surgical ablation will rest with minimally invasive approaches, commented Adam Saltman, M.D., of Maimonides Medical Center (Brooklyn, NY, USA). "The FlexView System greatly simplifies the endoscopic approach and will encourage a much broader adoption of the procedure. It is a significant step forward.”

The FlexView system was developed by Boston Scientific (Natick, MA, USA).

Most often, cardiac ablation is used to treat rapid heartbeats that begin in the upper chambers (atria) of the heart. As a group, these are known as supraventricular tachycardias (SVTs). Less frequently, ablation can treat heart-rhythm disorders that begin in the ventricles. The most common, ventricular tachycardia, may also be the most dangerous type of arrhythmia because it can cause sudden cardiac death. For patients at risk for sudden cardiac death, ablation often is used along with an implantable cardioverter device (ICD). The ablation decreases the frequency of abnormal heart rhythms in the ventricles and therefore reduces the number of ICD shocks a patient may experience.



Related Links:
Boston Scientific

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Newborn Hearing Screener
ALGO 7i
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.